Aligos Therapeutics Inc ALGS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
0.79quote price arrow down-0.0194 (-2.3948%)
Volume
421
Close
0.8101quote price arrow down-0.0359 (-4.2435%)
Volume
185,057
52 week range
0.54 - 1.38
Loading...
  • Open0.829
  • Day High0.85
  • Day Low0.7811
  • Prev Close0.846
  • 52 Week High1.38
  • 52 Week High Date05/04/23
  • 52 Week Low0.54
  • 52 Week Low Date10/24/23

Key Stats

  • Market Cap63.277M
  • Shares Out78.11M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta2.35
  • YTD % Change22

KEY STATS

  • Open0.829
  • Day High0.85
  • Day Low0.7811
  • Prev Close0.846
  • 52 Week High1.38
  • 52 Week High Date05/04/23
  • 52 Week Low0.54
  • 52 Week Low Date10/24/23
  • Market Cap63.277M
  • Shares Out78.11M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta2.35
  • YTD % Change22

RATIOS/PROFITABILITY

  • EPS (TTM)-1.82
  • P/E (TTM)-0.45
  • Fwd P/E (NTM)-0.96
  • EBITDA (TTM)-79.968M
  • ROE (TTM)-89.48%
  • Revenue (TTM)15.529M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-564.61%
  • Debt To Equity (MRQ)0.26%

EVENTS

  • Earnings Date05/07/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aligos Therapeutics Inc

 

Profile

MORE
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases. The Company discovers and develops therapeutics for metabolic dysfunction associated steatohepatitis (MASH) and viruses with high unmet medical need, such as chronic hepatitis B (CHB) and coronaviruses. Its advanced drug candidate for MASH is ALG-055009, a small molecule thyroid hormone receptor beta...
Lawrence Blatt Ph.D.
Chairman of the Board, Chief Executive Officer
Lesley Calhoun
Chief Financial Officer, Executive Vice President
Matthew Mcclure M.D.
Executive Vice President, Chief Medical Officer
Julian Symons Ph.D.
Executive Vice President, Chief Scientific Officer
Lucinda Quan J.D.
Executive Vice President, Chief Business Officer, General Counsel
Address
One Corporate Dr., 2nd Floor, 2nd Floor
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
CARM
Carisma Therapeutics Inc
1.62+0.02+1.25%
JAGX
Jaguar Health Inc
0.318+0.0248+8.4584%
IKNA
Ikena Oncology Inc
1.32UNCHUNCH
GRTS
Gritstone bio Inc
0.9627+0.0927+10.6552%
KZR
Kezar Life Sciences Inc
0.8574+0.0027+0.3159%